Agenda

On-Demand Sessions (Online Only)

Advances in Systemic Mastocytosis

Learning Objectives

  • Compare and contrast the recommended treatment regimens for different subtypes of systemic mastocytosis.
  • Evaluate the data for the emerging treatment options for systemic mastocytosis. 

This session offers pharmacotherapeutic hours for nurses.

Erdheim-Chester Disease: The Role of Molecular Testing in Treatment Planning

Learning Objectives

  • Discuss the importance of molecular testing in patients with Erdheim-Chester disease.
  • Describe the recommended treatment options for patients with Erdheim-Chester disease.

Individualizing Treatment for Patients with Waldenström Macroglobulinemia

Learning Objectives

  • Identify the role of molecular biomarkers in guiding individualized treatment selection for patients with Waldenström macroglobulinemia.
  • Compare the efficacy and safety profiles of regimens used in treatment of Waldenström macroglobulinemia and apply this evidence to clinical decision-making.

This session offers pharmacotherapeutic hours for nurses.

Psychosocial Support for Adolescent and Young Adult Patients with Hematologic Malignancies

Learning Objectives

  • Identify the current gaps in psychosocial resources and support for adolescent and young adult patients. 
  • Evaluate available resources that can provide psychosocial support to adolescent and young adult patients. 

The Evolving Treatment Landscape in Myeloproliferative Neoplasms

Learning Objectives

  • Compare and contrast the treatment options that are available for myeloproliferative neoplasms. 
  • Evaluate the data for emerging novel therapies for myeloproliferative neoplasms. 

This session offers pharmacotherapeutic hours for nurses.

Treating Adult Patients with Burkitt Lymphoma

Learning Objectives

  • Apply evidence-based strategies for the diagnosis, treatment and supportive care interventions for the management of newly diagnosed Burkitt lymphoma.
  • Assess the prognosis of disease relapse and implement a treatment plan for the management of relapsed disease.

This session offers pharmacotherapeutic hours for nurses.

Agenda is subject to change.

All times are listed as Eastern Daylight Time (UTC/GMT -4).